RASTREIO DO CÂNCER DE COLO DE ÚTERO EM INDIVÍDUOS TRANSMASCULINOS - REVISÃO DE LITERATURA

Autores

  • Ana Beatriz Stella Marques Mendes Universidade Católica de Brasília - UCB
  • Gabriela Ponte Gutierres Universidade Católica de Brasília - UCB
  • Victoria Piantino Universidade Católica de Brasília - UCB
  • Gabriela Furlan Ribeiro Barbosa Netto Universidade Católica de Brasília - UCB
  • Beatriz Regis da Cunha Universidade Católica de Brasília - UCB
  • Letícia Olivier Sudbrack Universidade Católica de Brasília - UCB

Resumo

Indivíduos transmasculinos (TM) que têm colo cervical podem desenvolver câncer de colo de útero (CCU) e, portanto, devem realizar exames de rastreio. Avanços referentes à saúde dessa minoria de gênero foram alcançados, entretanto muitas barreiras ainda tornam o rastreio do CCU deficitário.

Referências

AGÉNOR, Madina; HUGHTO, Jaclyn M. White; PEITZMEIER, Sarah M.; POTTER, Jennifer; DEUTSCH, Madeline B.; PARDEE, Dana J.; REISNER, Sari L.. Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults. Journal Of General Internal Medicine, [S.L.], v. 33, n. 7, p. 1015-1017, 13 abr. 2018. Springer Science and Business Media LLC. http://dx.doi.org/10.1007/s11606-018-4400-3.

AGÉNOR, Madina; PEITZMEIER, Sarah M.; BERNSTEIN, Ida M.; MCDOWELL, Michal; ALIZAGA, Natalie M.; REISNER, Sari L.; PARDEE, Dana J.; POTTER, Jennifer. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives. Culture, Health & Sexuality, [S.L.], v. 18, n. 10, p. 1192-1206, 4 maio 2016. Informa UK Limited. http://dx.doi.org/10.1080/13691058.2016.1177203.

BESWICK A, Corkum M, D'Souza D. Locally advanced cervical cancer in a transgender man. CMAJ, v. 191, n.3, p. 76-78, jan. 2019. doi: 10.1503/cmaj.181047. PMID: 30665977; PMCID: PMC6336482.

BROWN B, Poteat T, Marg L, Galea JT. Human Papillomavirus-Related Cancer Surveillance, Prevention, and Screening Among Transgender Men and Women: Neglected Populations at High Risk. LGBT Health, v. 4, n.5, p. 315-319, out. 2017. doi: 10.1089/lgbt.2016.0142.

CONNOLLY, Dean et al. Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review. Preventive Medicine, [S.L.], v. 135, p. 106071, jun.2020. Elsevier BV. http://dx.doi.org/10.1016/j.ypmed.2020.106071.

DHILLON, Navdeep; OLIFFE, John L.; KELLY, Mary T.; KRIST, Jennifer. Bridging Barriers to Cervical Cancer Screening in Transgender Men: a scoping review. American Journal Of Men'S Health, [S.L.], v. 14, n. 3, p. 155798832092569, maio 2020. SAGE Publications. http://dx.doi.org/10.1177/1557988320925691.

GATOS, Kayla C.. A Literature Review of Cervical Cancer Screening in Transgender Men. Nursing For Women'S Health, [S.L.], v. 22, n. 1, p. 52-62, fev. 2018. Elsevier BV. http://dx.doi.org/10.1016/j.nwh.2017.12.008.

JOHNSON MJ, Mueller M, Eliason MJ, Stuart G, Nemeth LS. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men. J Clin Nurs, [S.L], v. 25, n. 23-24, p. 3628-2642, dec. 2016. doi: 10.1111/jocn.13414.

JOHNSON MJ, Nemeth LS, Mueller M, Eliason MJ, Stuart GW. Qualitative Study of Cervical Cancer Screening Among Lesbian and Bisexual Women and Transgender Men. Cancer Nurs, [S.L.], v. 39, n. 6, p. 455-463, nov/dec. 2016. doi: 10.1097/NCC.0000000000000338. PMID: 26859282.

KIRAN T, Davie S, Singh D, Hranilovic S, Pinto AD, Abramovich A, Lofters A. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician, [S.L.], v. 65, n. 1, p. 30-37, jan. 2019. PMID: 30674526; PMCID: PMC6347308.

MCDOWELL M, Pardee DJ, Peitzmeier S, Reisner SL, Agénor M, Alizaga N, Bernstein I, Potter J. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests. LGBT Health, v. 4, n.4, p. 252-259, ago. 2017. doi: 10.1089/lgbt.2016.0187. PMID: 28665783.

PEITZMEIER, Sarah M.; AGÉNOR, Madina; BERNSTEIN, Ida M.; MCDOWELL, Michal; ALIZAGA, Natalie M.; REISNER, Sari L.; PARDEE, Dana J.; POTTER, Jennifer. “It Can Promote an Existential Crisis”: factors influencing pap test acceptability and utilization among transmasculine individuals. Qualitative Health Research, [S.L.], v. 27, n. 14, p. 2138-2149, 24 ago. 2017. SAGE Publications. http://dx.doi.org/10.1177/1049732317725513.

SALLANS RK. Six Tips for Giving Good Health Care to Anyone With a Cervix. AMA J Ethics, v. 22, n. 2, p. 168-175, fev. 2020. doi: 10.1001/amajethics.2020.168. PMID: 32048589.

SEAY, Julia; RANCK, Atticus; WEISS, Roy; SALGADO, Christopher; FEIN, Lydia; KOBETZ, Erin. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: a rapid assessment survey. Lgbt Health, [S.L.], v. 4, n. 4, p. 304-309, ago. 2017. Mary Ann Liebert Inc. http://dx.doi.org/10.1089/lgbt.2016.0143.

SHIRES DA, Prieto L, Woodford MR, Jaffee KD, Stroumsa D. Gynecologic Health Care Providers' Willingness to Provide Routine Care and Papanicolaou Tests for Transmasculine Individuals. J Womens Health (Larchmt), [S.L.], v. 28, n. 11, p. 1487-1492, nov. 2019. doi: 10.1089/jwh.2018.7384. Epub ago. 2019. PMID: 31411513.

WEYERS, S et al. Cervical cancer prevention in transgender men: a review. Bjog: An International Journal of Obstetrics & Gynaecology, [S.L.], v. 128, n. 5, p. 822-826, 2 out. 2020. Wiley. http://dx.doi.org/10.1111/1471-0528.16503.

Downloads

Publicado

2021-09-10

Edição

Seção

Revisão de Literatura